Clinical Trial Update: A Study in Asthmatic Patients to Determine if There is Any Difference in Dosing With Fluticasone Furoate/Vilanterol Inhalation Powder in the Morning or Evening on Lung Function [Phase 2]

View source ↗

Summary

A Phase 2 study in asthma examined whether morning or evening dosing of fluticasone furoate/vilanterol inhalation powder yields different effects on lung functi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone furoate/vilanterol inhalation powder (fluticasone furoate/vilanterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2013-08-09